← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2025-03-31 · Filed 2025-05-15 · Accession 0001420506-25-001293
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | AARDVARK THERAPEUTICS INC | COM · 002942100 | LONG | 500,000 | $3.8 million |
| 2 | ADAPTIVE BIOTECHNOLOGIES COR | COM · 00650F109 | LONG | 4,803,794 | $35.7 million |
| 3 | AEROVATE THERAPEUTICS INC | COM · 008064107 | LONG | 1,440,499 | $3.6 million |
| 4 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 530,530 | $84.3 million |
| 5 | ALPHATEC HLDGS INC | COM NEW · 02081G201 | LONG | 4,259,429 | $43.2 million |
| 6 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 5,818,000 | $5.8 million |
| 7 | APELLIS PHARMACEUTICALS INC | COM · 03753U106 | LONG | 1,652,334 | $36.1 million |
| 8 | APOGEE THERAPEUTICS INC | COM · 03770N101 | LONG | 1,540,362 | $57.5 million |
| 9 | ARGENX SE | SPONSORED ADR · 04016X101 | LONG | 160,849 | $95.2 million |
| 10 | ASCENDIS PHARMA A/S | SPONSORED ADR · 04351P101 | LONG | 106,713 | $16.6 million |
| 11 | BETA BIONICS INC | COM · 08659B102 | LONG | 140,000 | $1.7 million |
| 12 | BICARA THERAPEUTICS INC | COM · 055477103 | LONG | 2,162,803 | $28.2 million |
| 13 | BLUEPRINT MEDICINES CORP | COM · 09627Y109 | LONG | 439,968 | $38.9 million |
| 14 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 48,594,000 | $43.8 million |
| 15 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 62,838,000 | $72.0 million |
| 16 | CASTLE BIOSCIENCES INC | COM · 14843C105 | LONG | 365,247 | $7.3 million |
| 17 | CELCUITY INC | COM · 15102K100 | LONG | 884,306 | $8.9 million |
| 18 | CG ONCOLOGY INC | COM · 156944100 | LONG | 3,283,317 | $80.4 million |
| 19 | CULLINAN THERAPEUTICS INC | COM · 230031106 | LONG | 980,773 | $7.4 million |
| 20 | DANAHER CORP DEL | COM · 235851102 | LONG | 309,339 | $63.4 million |
| 21 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 3,536,853 | $28.0 million |
| 22 | DEXCOM INC | NOTE 0.250%11/1 · 252131AK3 | LONG | 18,500,000 | $18.0 million |
| 23 | DEXCOM INC | NOTE 0.375% 5/1 · 252131AM9 | LONG | 25,450,000 | $22.8 million |
| 24 | DIANTHUS THERAPEUTICS INC | COM · 252828108 | LONG | 375,355 | $6.8 million |
| 25 | DYNE THERAPEUTICS INC | COM · 26818M108 | LONG | 3,621,344 | $37.9 million |
| 26 | EDGEWISE THERAPEUTICS INC | COM · 28036F105 | LONG | 2,458,808 | $54.1 million |
| 27 | GLAUKOS CORP | COM · 377322102 | LONG | 624,435 | $61.5 million |
| 28 | GUARDANT HEALTH INC | COM · 40131M109 | LONG | 1,327,327 | $56.5 million |
| 29 | GUARDANT HEALTH INC | DEBT 1.250% 2/1 · 40131MAD1 | LONG | 219,454,000 | $227.4 million |
| 30 | HARROW INC | COM · 415858109 | LONG | 956,839 | $25.5 million |
| 31 | IMMUNOCORE HLDGS PLC | NOTE 2.500% 2/0 · 45258DAB1 | LONG | 51,828,000 | $43.8 million |
| 32 | INSPIRE MED SYS INC | COM · 457730109 | LONG | 302,410 | $48.2 million |
| 33 | INTUITIVE SURGICAL INC | COM NEW · 46120E602 | LONG | 88,000 | $43.6 million |
| 34 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 556,391 | $58.2 million |
| 35 | IRHYTHM TECHNOLOGIES INC | NOTE 1.500% 9/0 · 450056AB2 | LONG | 86,000,000 | $89.7 million |
| 36 | IRONWOOD PHARMACEUTICALS INC | COM CL A · 46333X108 | LONG | 6,622,584 | $9.7 million |
| 37 | IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 · 46333XAH1 | LONG | 92,740,000 | $82.5 million |
| 38 | KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A · G52694109 | LONG | 1,962,909 | $43.6 million |
| 39 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 400,744 | $72.3 million |
| 40 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 2,977,951 | $101.0 million |
| 41 | MADRIGAL PHARMACEUTICALS INC | COM · 558868105 | LONG | 48,690 | $16.1 million |
| 42 | MARAVAI LIFESCIENCES HLDGS I | COM CL A · 56600D107 | LONG | 8,353,287 | $18.5 million |
| 43 | METSERA INC | COM · 59267L107 | LONG | 175,000 | $4.8 million |
| 44 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 101,381,000 | $87.9 million |
| 45 | NEUROCRINE BIOSCIENCES INC | COM · 64125C109 | LONG | 1,191,925 | $131.8 million |
| 46 | NOVOCURE LTD | NOTE 11/0 · 67011XAB9 | LONG | 140,834,000 | $136.6 million |
| 47 | NUVALENT INC | COM · 670703107 | LONG | 840,945 | $59.6 million |
| 48 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 1,107,770 | $27.3 million |
| 49 | ORUKA THERAPEUTICS INC | COM · 687604108 | LONG | 1,572,426 | $16.1 million |
| 50 | PENUMBRA INC | COM · 70975L107 | LONG | 110,128 | $29.4 million |
| 51 | PULMONX CORP | COM · 745848101 | LONG | 752,541 | $5.1 million |
| 52 | REPLIGEN CORP | COM · 759916109 | LONG | 81,656 | $10.4 million |
| 53 | REPLIGEN CORP | NOTE 1.000%12/1 · 759916AD1 | LONG | 98,000,000 | $95.8 million |
| 54 | REPLIMUNE GROUP INC | COM · 76029N106 | LONG | 1,461,826 | $14.3 million |
| 55 | SAREPTA THERAPEUTICS INC | COM · 803607100 | LONG | 234,500 | $15.0 million |
| 56 | SKYE BIOSCIENCE INC | COM NEW · 83086J200 | LONG | 825,732 | $1.3 million |
| 57 | SPYRE THERAPEUTICS INC | COM NEW · 00773J202 | LONG | 2,578,404 | $41.6 million |
| 58 | THERMO FISHER SCIENTIFIC INC | COM · 883556102 | LONG | 127,733 | $63.6 million |
| 59 | TRANSMEDICS GROUP INC | COM · 89377M109 | LONG | 854,884 | $57.5 million |
| 60 | TREVI THERAPEUTICS INC | COM · 89532M101 | LONG | 72,083 | $453,402 |
| 61 | VIKING THERAPEUTICS INC | COM · 92686J106 | LONG | 1,435,955 | $34.7 million |
| 62 | XENCOR INC | COM · 98401F105 | LONG | 1,655,690 | $17.6 million |
| 63 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 2,709,875 | $90.9 million |
| 64 | ZURA BIO LTD | CLASS A ORD SHS · G9TY5A101 | LONG | 2,472,806 | $3.2 million |